VWF and hemolytic-uremic syndrome: For example, it is not entirely clear if altered complement activity, a key feature of D-HUS, or abnormal von Willebrand factor in TTP also have a role in predisposing some individuals to the action of Shiga toxin in D+HUS (typical HUS) [12,13].